S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Mine OK'd in Trump's last days may boost Biden energy plan
DuPont, Chemours reach agreement over 'forever chemicals'
Indonesia says it has seized Iranian and Panamanian tankers
Trapped for 2 weeks, 11 workers rescued from China gold mine
One of 22 workers trapped in China gold mine rescued
The Latest: Short on bed space, Brazilian state locks down
Normal diets for trapped China miners as rescue continues
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Mine OK'd in Trump's last days may boost Biden energy plan
DuPont, Chemours reach agreement over 'forever chemicals'
Indonesia says it has seized Iranian and Panamanian tankers
Trapped for 2 weeks, 11 workers rescued from China gold mine
One of 22 workers trapped in China gold mine rescued
The Latest: Short on bed space, Brazilian state locks down
Normal diets for trapped China miners as rescue continues
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Mine OK'd in Trump's last days may boost Biden energy plan
DuPont, Chemours reach agreement over 'forever chemicals'
Indonesia says it has seized Iranian and Panamanian tankers
Trapped for 2 weeks, 11 workers rescued from China gold mine
One of 22 workers trapped in China gold mine rescued
The Latest: Short on bed space, Brazilian state locks down
Normal diets for trapped China miners as rescue continues
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Mine OK'd in Trump's last days may boost Biden energy plan
DuPont, Chemours reach agreement over 'forever chemicals'
Indonesia says it has seized Iranian and Panamanian tankers
Trapped for 2 weeks, 11 workers rescued from China gold mine
One of 22 workers trapped in China gold mine rescued
The Latest: Short on bed space, Brazilian state locks down
Normal diets for trapped China miners as rescue continues
Log in
CNSX:PMC

Pharmerica Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
$0.08
MA: $0.08▼
$0.09
52-Week Range N/A
Volume13,000 shs
Average Volume5,703 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Peloton Minerals Corporation, a mineral exploration company, acquires and explores for mineral properties in Canada and the United States. The company primarily explores for gold and silver deposits. It principally owns three gold exploration projects located in Elko County, Nevada; and one gold exploration project in Montana, the United States. The company was formerly known as Montana Gold Mining Company Inc. and changed its name to Peloton Minerals Corporation in 2016. Peloton Minerals Corporation was incorporated in 2000 and is headquartered in London, Canada.

MarketRank™

Overall MarketRank™

0.54 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange CNSX
Industry Gold
Sub-IndustryN/A
SectorBasic Materials
Current SymbolCNSX:PMC
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.pharmerica.com
Phone519-964-2836
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive PMC News and Ratings via Email

Sign-up to receive the latest news and ratings for PMC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Pharmerica (CNSX:PMC) Frequently Asked Questions

What stocks does MarketBeat like better than Pharmerica?

Wall Street analysts have given Pharmerica a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Pharmerica wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Pharmerica's key competitors?

Some companies that are related to Pharmerica include (ASE) (ASE), (GOLD.V) (GOLD), (PGO.AX) (PGO), (RLG) (RLG), 3737 (RFR), Aben Resources (ABNAF), AIC Mines Limited (A1M.AX) (A1M), Alacer Gold (ALIAF), ALACERGOLD/IDR UNRESTR (AQG), Alchemy Resources Limited (ALY.AX) (ALY), Alliance Resources Limited (AGS.AX) (AGS), Amani Gold Limited (ANL.AX) (ANL), American CuMo Mining Co. (MLY.V) (MLY), Amex Exploration (AMXEF) and Anaconda Mining (ANXGF).
View all of PMC's competitors.

What other stocks do shareholders of Pharmerica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pharmerica investors own include Enbridge Inc. (ENB.TO) (ENB), Delta Air Lines (DAL), Air Canada (AC.TO) (AC), TELUS Co. (T.TO) (T), Fortis Inc. (FTS.TO) (FTS), Ford Motor (F), Enterprise Products Partners (EPD), Capital Power Co. (CPX.TO) (CPX), Bank of America (BAC) and The Boeing (BA).

Who are Pharmerica's key executives?

Pharmerica's management team includes the following people:
  • Mr. Edward L. Ellwood M.B.A., MBA, Pres, CEO & Director (Age 61, Pay $120k)
  • Mr. Eric J. Plexman, Corp. Sec., CFO & Director (Age 68, Pay $60k)
  • Mr. Richard Crissman Capps Ph.D., Independent Sr. Geologist & Director
  • Mr. Paul V. Teodorovici, Exec. VP & Director
  • Mr. Paul Strobel, VP of Marketing & Bus. Devel. (Age 74)

What is Pharmerica's stock symbol?

Pharmerica trades on the CNSX under the ticker symbol "PMC."

How do I buy shares of Pharmerica?

Shares of PMC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pharmerica's official website?

The official website for Pharmerica is www.pharmerica.com.

How can I contact Pharmerica?

The company can be reached via phone at 519-964-2836.

This page was last updated on 1/24/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.